Option Care Health Inc
For the period ended Dec 31, 2023. Filed Feb 22, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 22, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on February 22, 2024.
OPTION CARE HEALTH, INC.
/s/ Michael Shapiro
Michael Shapiro
Chief Financial Officer and Executive Vice President(Principal Financial Officer and Duly Authorized Officer)
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities on the dates indicated.
| Signature | Title(s) | Date |
|---|---|---|
| /s/ John C. RademacherJohn C. Rademacher | Chief Executive Officer, President and Director (Principal Executive Officer) | February 22, 2024 |
| /s/ Michael ShapiroMichael Shapiro | Chief Financial Officer and Executive Vice President (Principal Financial Officer and Principal Accounting Officer) | February 22, 2024 |
| /s/ Harry M. Jansen Kraemer, Jr.Harry M. Jansen Kraemer, Jr. | Non-Executive Chairman of the Board | February 22, 2024 |
| /s/ John J. ArlottaJohn J. Arlotta | Director | February 22, 2024 |
| /s/ Elizabeth Q. BettenElizabeth Q. Betten | Director | February 22, 2024 |
| /s/ Elizabeth D. BierbowerElizabeth D. Bierbower | Director | February 22, 2024 |
| /s/ Barbara W. BodemBarbara W. Bodem | Director | February 22, 2024 |
| /s/ Natasha DeckmannNatasha Deckmann | Director | February 22, 2024 |
| /s/ David W. GoldingDavid W. Golding | Director | February 22, 2024 |
| /s/ R. Carter PateR. Carter Pate | Director | February 22, 2024 |
| /s/ Timothy P. SullivanTimothy P. Sullivan | Director | February 22, 2024 |
| /s/ Norman L. WrightNorman L. Wright | Director | February 22, 2024 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.